All posts by imreal

Quick’rCare Strengthens its Advisory Board with Appointment of Innovative Physician Executive Dr. Gerald Maccioli


“Quick’ rCare expertly facilitates patient access and improves the patient experience.” – Dr. Gerald Maccioli

Quick’rCare is pleased to announce that Gerald Maccioli, M.D., MBA, FCCM, FASA has been named to our Advisory Board. Quick’rCare has worked to solve part of the quality of care equation by being a platform for empowering patients to guide them to their nearest healthcare facility to seek help, feel safe, and wait less for their health. We believe that by listening to and understanding the patient & clinicians’ experience, we can transform and improve healthcare access.

“I am honored to join the Quick’rCare team,” said Dr. Maccioli. “Quick’rCare expertly facilitates patient access and improves the patient experience.”

Dr. Maccioli is the former Chief Quality Officer for Envision Healthcare. He has been nominated as one of Modern Healthcare’s 50 Most Influential Physician Executives and Leaders. He is an innovative physician executive with a history of patient-centric clinical and business leadership experience. His peers and community well respect him for his dedication to enhancing care and access for patients and clinicians.

“Innovative, patient-focused, clinician-friendly care delivery has been an important theme driving our technology strategy since the beginning. We believe Dr. Maccioli’s history and insights will be an enormously valuable addition to the Quick’rCare team,” said Quick’rCare CEO, Alex Guastella. “As we approach the new path of healthcare COVID-19 has provided, we look forward to working with Dr. Maccioli to simplify the digital health experience to provide better quality, proper access, and savings.”

About Quick’rCare

In 2016, serial entrepreneurs Alex Guastella and Raghu Dhulipala joined forces to solve digital problems that sick patients face every day. Quick’rCare was created through much deliberation to be a guidance platform that will help the 145 million people who end up in the emergency room every year. Since its inception, Quick’rCare has helped over a million patients, added over 20 team members, and brought on great investors. Whether through the technology created or the volunteer hours served, the people behind Quick’rCare have a mantra of always doing good for others.

Share article on social media or email:

Ron Meskis, Co-CEO and Charley Read, COO


Our pivotal moment for continuing to innovate and build this vital organization to its fullest potential is now, and we trust this new leadership team will successfully implement our growth strategy with a keen focus and commitment to excellence for our customers throughout the country.

Simplex-USA, the foremost manufacturer and supplier of infrastructure products to highway contractors throughout the USA and Canada, has added to its growth with the leadership joint appointments of Ron Meskis as Co-Chief Executive Officer and Charley Read as Chief Operations Officer; it was announced today by Mark Kaler, the organization’s Interim Chief Executive Officer, who will continue to serve in a Co-CEO capacity:

“Considering the dedicated efforts of Meskis and Read, how both have been instrumental in building Simplex into the leading manufacturer and supplier of infrastructure products and solutions nationwide, their new appointments couldn’t be more deserved and complementary to each other’s strengths at this critical time of expansion. Our pivotal moment for continuing to innovate and build this vital organization to its fullest potential is now, and we trust this new leadership team will successfully implement our growth strategy with a keen focus and commitment to excellence for our customers throughout the country.”

The Simplex Board of Directors look to Meskis and Read in their new roles as part of completing the organization’s proliferation and relocation of its West Coast manufacturing operations to Fernley, NV. In addition to his new responsibilities as Co-CEO, Meskis will oversee all Simplex sales initiatives; while Read will be responsible for all company operations across its national footprint.

Meskis brings 30 years’ experience in the construction industry, with the last ten years serving as part of executive leadership teams in highly regarded construction and healthcare organizations. His significant expertise is recognized for successfully implementing strategic business plans through the utilization of Lean, Six Sigma, Theory of Constraints, and Value Selling. In only his past two years at Simplex, Meskis helped lead the team to increase the company’s gross profits over 50% growing revenues to over $90M (via acquisition and organic growth), and improving gross margins by 4% through optimizing operations. His collective sales and operational experience, compounded by his ability to embrace change, inspire a solid work ethic as he fosters a positive work culture. An immensurate leadership talent, Meskis has leveraged his role as the resolute leader for taking Simplex to its next level.

Read represents 27 years of leadership experience as a consultant and manager in manufacturing operations and professional services; specifically in construction, agriculture, automotive, and general industrial. His specializations include: Lean Manufacturing, Six Sigma, Operations/Facilities Management, and Project Management. Read was instrumental in leading DFSS 6 Sigma Black Belt projects into development, implementation, and improved key performance metrics for clients – being responsible for most recently leading a $2.5M project to move its manufacturing facility from Ontario, California to Fernley, Nevada. Before assuming the role of COO, Read has served as the General Manager of Dayton Superior’s paving division and has been part of the Simplex leadership team since its acquisition of Dayton Superior’s paving division in June 2019.

Sarah Bazey, founder of Simplex who lead and managed this company for more than 30 years as its CEO, and who most recently navigated Simplex’s purchase of JC Supply & Manufacturing, states: “We proudly recognize the outstanding efforts of Meskis and Read along with their continued dedication to Simplex. These accomplished individuals have the right combination of leadership skills, both in sales and operations, to deliver best-in-class manufacturing and financial performance, as well as to serve as successful ambassadors for our employees and valued customers.”

Paving continued growth and further acquisitions are chiefly in the Simplex ambit as the foremost leader of specialty road products. Now made even stronger through the newly appointed joint leadership of Meskis and Read, the company is steadfast at the vanguard of the industry future, distinctly poised to blaze those trails.

More About Simplex-USA

Excellence in Design Life and Quality of Concrete Pavement

Simplex is the pre-eminent manufacturer and supplier of infrastructure products to highway contractors throughout the USA and Canada. As an added benefit to contractors, Simplex is recognized for its proficiency in bundling the most comprehensive and customized package of accessories for its customers. Upholding a blue-chip standard, the company has continued to distinguish its strength and reputation; garnering widespread growth and industry demand. Simplex has perfected the ability to create innovative new products that improve the design life and overall quality of concrete pavement. As a result of its more than 150 years of experience, the Simplex team has become a trusted partner to its loyal customers, which have increasingly relied upon this exemplary industry leader for providing all needed expert technical guidance and proven solutions. This includes servicing the state and federal authorities, which approve the Simplex products for use in concrete roads and airport pavements.

Simplex maintains a combined footprint of 448,000 square feet under roof and 25 acres of capacity across three locations comprised of Fernley, Nevada; Kankakee, Illinois; and Minneapolis, Minnesota; with over 150 employees combined working in those facilities.

Share article on social media or email:

Asana Recovery Hires Author and Speaker, Tanya Brown, as New Clinical Outreach Coordinator


Asana Recovery Tanya Brown

Tanya Brown for Asana Recovery Clinical Outreach

“I am excited to find a way to use my background and passion for mental health to increase awareness about Asana Recovery’s treatment programs,” says Ms. Brown. “I believe that treatment is key to mental health, and tackling unresolved trauma is the first step to recovery.”

Asana Recovery recently appointed Tanya Brown as clinical outreach coordinator and will be part of the business development team. In this role, Ms. Brown will be responsible for identifying, securing, developing, and maintaining referral relationships with professionals in the addiction and behavioral health industries. With over two decades of experience as a speaker, as well as author and advocate of mental health, she will develop lectures and presentations that highlight the importance of mental health, treatment, and recovery.

Tanya Brown is no stranger to the adversity of trauma. The loss of her sister, Nicole Brown Simpson, more than 20 years ago was a personal and family tragedy that topped national and international headlines. She has faced overwhelming life challenges, which served as the force to ultimately improve the quality of her life. She has become a nationally recognized author, speaker and life coach who uses the lessons from her experience to help others cope with life’s challenges.

“I am excited to find a way to use my background and passion for mental health to increase awareness about Asana Recovery’s treatment programs,” says Ms. Brown. “I believe that treatment is key to mental health, and tackling unresolved trauma is the first step to recovery.”

Ms. Brown is the author of “Finding Peace Amid the Chaos” and “The Seven Characters of Abuse”. She holds a master’s degree in Counseling Psychology.

Asana Recovery offers unique and innovative ways to treat the disease of addiction. Harnessing the efficacy of traditional, evidenced-based methods, while incorporating alternative techniques, the “Asana Way” incorporates a full-spectrum of services to treat clients for each and every phase of addiction recovery. For more information about Asana Recovery treatment programs, visit http://www.AsanaRecovery.com

About Asana Recovery

Asana Recovery is a private, for-profit, health care organization located in Costa Mesa, California. Asana Recovery provides a complete and individualized addiction treatment program using traditional as well as innovative or alternative methods to treat addiction. It provides 24/7 supervised support with round-the-clock staff onsite. Its mission is to provide a healing environment where clients acknowledge and understand their addiction, embrace a lifestyle of productivity, and find the fulfillment that comes in serving others. Asana Recovery is accredited by The Joint Commission, ASAM Level of Care certified, CARF accredited, and licensed by the Department of Health Care Services (DHCS) in California. More information about Asana Recovery can be found online at http://www.asanarecovery.com.

Share article on social media or email:

Dracen announces two DRP-104 presentations at AACR


Dracen Pharmaceuticals Inc., announced today that two posters profiling its lead glutamine antagonist, DRP-104, will be presented June 22-24 during the American Association for Cancer Research Virtual meeting. One poster describes the immuno-metabolism and anti-cancer effects of DRP-104; and, the other profiles the potent, consistent single agent activity in KEAP1 mutant tumor models of NSCLC.

“As our lead asset DRP-104 advances in phase I clinical development, our preclinical data continues to confirm its promising profile both as a single agent and in combination therapy” said Robert Wild, Ph.D. Chief Scientific Officer of Dracen Pharmaceuticals. “The data being presented at AACR demonstrates that DRP-104 has a significant direct effect on tumors as well as profound remodeling of the tumor microenvironment; the latter leading to stimulation of both the innate as well as the adaptive immune systems resulting in therapeutic synergy with checkpoint inhibitors. Additionally, DRP-104 has demonstrated potent and broad antitumor activity in both murine and patient derived lung adenocarcinoma and squamous tumor models with KEAP1 mutations. The data suggests that DRP-104 is a promising therapy to treat KEAP1 mutant lung cancers and we are excited about advancing this promising compound in the clinic.”

The presentation details are as follows:

Broad Acting Glutamine Antagonism Remodels the Tumor Microenvironment; Induces Distinctive Immune Modulation; and, Synergizes with Immune Checkpoint Blockade

Abstract Date: June 22nd at 9:00 am – 6:00 pm

Abstract ID: 5607

Uncovering metabolic bottlenecks in KEAP1 mutant lung cancer

Abstract Date: June 22nd at 9:00 am – 6:00 pm

Abstract ID: 2569

About DRP-104

Our lead glutamine antagonist, DRP -104, is currently in early stage clinical development. The mechanisms of action for DRP-104 include: a) direct inhibition of tumor cell addiction to glutamine leading to substantial single agent activity and tumor regression; b) broad metabolic remodeling of the tumor microenvironment leading to enhanced anti-tumor immune activity; and, c) stimulation of T effector, NK and NKT cells and inhibition of immunosuppressive MDSC and macrophage cells, leading to greater long-term durable responses and survival.

About Dracen Pharmaceuticals

Dracen Pharmaceuticals, Inc. is a privately held biotech company developing proprietary anti-cancer drugs that target immuno-metabolism. Dracen’s investors include Deerfield Management; Osage University Partners; and The Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague). Dracen is headquartered in New York, NY with research operations in San Diego, CA.

Share article on social media or email:

Spinning Babies® 2020 World Confluence now offered online


“As a midwife, I’ve developed a new approach to address fetal position and overall comfort. The result? Progress in labor and less pain in childbirth.”

Spinning Babies®, champion of a physiological approach to maternity health, pregnancy, and birth, have just announced that the Spinning Babies® 2020 World Confluence Pre-Conference and Main Conference will be delivered online. This development is offered as a response to the world health situation and pandemic, which may limit travel and group gatherings.

The 2020 World Confluence will be held in-person in Caloundra, Australia on October 17 & 18, 2020. The Pre-Conference – Informed Consent will be held on October 16, 2020. Participants may now attend in person in Caloundra, Australia or online through a virtual event platform.

Spinning Babies® will provide 56 hours of on-demand streams of expert speakers from around the world. Participants will have access to the event streams for thirty days after the event streams live. Participants will also be able to connect with event speakers, network with other participants, collect a virtual swag bag, and plan their own conference agenda using the virtual platform.

Up to 30 hours of continuing education credits will be available for approved speaker presentations.

Spinning Babies® promotes a unique approach to pregnancy comfort, labor progress, and easier birth using Physiology Before Force℠ for pregnant people, midwives and nurses, childbirth educators, and pregnancy-focused bodyworkers.

“As a midwife, I’ve developed a new approach to address fetal position and overall comfort. The result? Progress in labor and less pain in childbirth.” – Gail Tully, CPM, Spinning Babies® Founder & CEO

More information on the 2020 World Confluence speakers, schedule, and offerings can be found online at https://spinningbabies.com/2020confluence/.

Share article on social media or email:

Clinerion’s Patient Network Explorer offers clinical trial performance data for sites in its global site network


Effective immediately, users of Clinerion’s Patient Network Explorer can review detailed clinical trial statistics on an individual hospital level. Derived and mapped from multiple public sources, this new functionality allows for browsing, filtering, reviewing, and comparing site trial performance statistics, including breakdowns on studies by sponsor, by condition, by trial phase and by recruitment status.

The possibility to further filter by study status, sponsor, phase, or condition offers detailed results and a list of the respective studies which provides more information such as on other locations where the study is being conducted.

“It is crucial, during site selection, to have as much information at hand as possible, to avoid expensive detours and dead ends,” says Ian Rentsch, CEO of Clinerion. “Patient Network Explorer is becoming everything a sponsor needs to identify the right site for their trials.”

Clinical trial performance data in this service is powered by LongTaal. For more information, please visit: http://www.longtaal.com

About Clinerion

Clinerion accelerates clinical research and medical access to treatments for patients. We generate real-world data from our global network of partner hospitals for Real World Evidence analyses. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments.

Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. Researchers gain access to real-time, longitudinal patient data from electronic health records for analysis. We enable pharmaceutical companies, CROs and SMOs to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s Patient Network Explorer also provides a platform for integration of diverse patient data sources into real-world data ecosystems. Clinerion’s proprietary technologies comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.

Clinerion website: http://www.clinerion.com

Clinerion’s Patient Network Explorer: http://www.clinerion.com/index/PatientNetworkExplorerSolutions.html

For more information, please contact:

Le Vin Chin

Director, Head of Marketing & Communications

Clinerion Ltd

Elisabethenanlage 11, 4051 Basel, Switzerland

Tel.: +41 61 865 60 54

media@clinerion.com

Share article on social media or email:

U.S. Dermatology Partners Georgetown, formerly Georgetown Dermatology & Skin Cancer Center, is pleased to announce the addition of David Ettinger, PA-C, June 22nd


Georgetown Dermatology PA David Ettinger, PA-C

David Ettinger, PA-C

U.S. Dermatology Partners Georgetown is excited to welcome David Ettinger, PA-C. Born and raised in the state of Washington, David relocated after high school and has lived in California, Arizona, and South America. He attended Northern Arizona University to obtain his Bachelor of Science before earning his Master of Physician Assistant Studies at the University of Washington School of Medicine in Seattle.

Since graduating, David Ettinger has worked in dermatology and craniofacial reconstructive plastic surgery with a focus in pediatrics. He loves dermatology and helping others feel more comfortable in their skin and providing relief to those struggling with various skin conditions.

He has participated in clinical research trials for psoriasis and “Spray-on Skin” to determine their efficacy and safety in the pediatric population. “It has been wonderful to be part of the process to find new ways to treat and provide relief to those suffering”, says David, a member of the Society of Dermatology Physician Assistants (SDPA).

As a physician assistant with several years of dermatology experience, David will treat patients with medical dermatology concerns such as acne treatment, psoriasis, rosacea, and eczema. He welcomes both adult and pediatric patients at our Georgetown, Texas dermatology clinic.

David Ettinger feels lucky to be raising 3 energetic, loving children alongside his wife. They enjoy spending time on the lake, exercising, and watching their children participate in their weekend sporting events.

U.S. Dermatology Partners Georgetown has been serving the dermatology needs of Georgetown and the Central Texas community since 2003. Founded by Dr. Kevin Miller, the Georgetown dermatology group includes Board-Certified Dermatologists, Dr. Monica Madray, Dr. Elizabeth Morris, Dr. Weilan Johnson, Fellowship-Trained Mohs Surgeon, Dr. Nicholas Snavely, Certified Physician Assistant David Ettinger, PA-C, and Licensed Aesthetician Corey Stoever, LA.

The state-of-the-art dermatology office was expanded in 2011 to meet the growing patient demand. U.S. Dermatology Partners Georgetown offers a full suite of clinical and surgical services, including Mohs surgery for the treatment of skin cancer. The providers treat conditions like acne, psoriasis and eczema to relieve or improve symptoms that limit your comfort, health and enjoyment. We provide specialized, highly effective treatments for a variety of skin cancers to restore and extend the quality of your life. The providers, who are parents of young children, feel comfortable treating patients of all ages, from the very young to the retirees of the Sun City community.

For more information or to schedule a new appointment, please contact the office at (512) 819-9910.

About U.S. Dermatology Partners

As one of the largest physician-owned dermatology practices in the country, U.S. Dermatology Partners’ patients not only have access to general medical, surgical, and cosmetic skin treatments through its coordinated care network, but also benefit from the practice’s strong dermatology subspecialty thought leaders and medical advisory board. To be the best partners to its patients, U.S. Dermatology Partners is fervently focused on providing the highest level of patient-first care, and its team, therefore, includes recognized national leaders in areas such as clinical research, psoriasis, and Mohs Surgery. To learn more, visit usdermatologypartners.com.

Share article on social media or email:

Announcing The Launch of Partners Medication Management LLC


News Image

The Care One Integrated Healthcare Network is pleased to announce the launch of Partners Medication Management, LLC. Partners Medication Management provides services promoting safe transitions of care and comprehensive medication management.

Partners Medication Management offers MedRec360 by Partners, a medication reconciliation report combined with pharmacist guidance ensuring healthcare providers have the best information to manage medication transitions of care at all levels.

Partners Medication Management will coordinate care from discharge to home by providing clear and timely communication between patients, caregivers, home health workers, and medical providers. Direct patient connection with pharmacy professionals facilitates safe medication practices preventing adverse events and re-hospitalizations.

“MedRec360 by Partners is a complete medication reconciliation and medication review made available to a provider within 24 hours of transition,” stated Jim Matthews, EVP of Operations. “This powerful solution provides a comprehensive view of a patient’s hospital and community based prescriptions with recommendations for insightful ease of use while helping to prevent unnecessary re-hospitalizations due to medication errors.”

Partners offers cost containment strategies as well as formulary management products for providers and payers financially at risk. Formulary management and plan design facilitated by proprietary PBM programming will create meaningful savings for customers by returning control over pharmaceutical spending to the healthcare provider.

About the CareOne Integrated Healthcare Network: The CareOne Integrated Healthcare Network is designed to provide total continuity of care across every aspect of a patient or resident’s healthcare journey including assisted living, long term care, post-acute rehabilitation, long term acute care, memory care, home care, hospice and palliative and pharmaceutical services. No matter the care need, the CareOne Integrated Healthcare Network ensures coordinated and seamless care for every patient or resident providing the quality, personalized experience they need and deserve.    

For more information regarding Partners Medication Management, please contact Jim Matthews, EVP of Operations at jmatthews@partnerspharmacy.com.

For information regarding the CareOne Integrated Healthcare Network, please contact Patricia Chiorello, SVP of Communications at pchiorello@care-one.com.

Share article on social media or email:

Important Notice of Voluntary Recall Of Charging Cables In Certain Relay Units


Republic Wireless today announced a voluntary recall of a limited number of older Relay charging cables that may overheat and pose a burn risk. Republic is aware of 2 incidents of cables overheating. No injuries have been reported.

The affected cables were included with Relays sold primarily between May 2018 and Nov 2018 at Relaygo.com, Target, and Amazon.

The recall does not affect Relay charging cables with the logo imprinted on the charging head.

Out of an abundance of caution, and because customer safety is a top priority, Republic Wireless is asking customers to stop using affected cables. Customers with affected cables and active accounts will be notified via email and receive replacement cables free of charge. For more details on this voluntary recall and how to get a replacement cable, go to relaygo.com/cableinfo.

Share article on social media or email:

Village Dermatology expands to serve patients in the Gardendale area


Village Dermatology has been serving the Birmingham area for over a decade now. Currently, the dermatology practice has a central location in Mountain Brook with satellite locations in Blount County and off of Hwy 280 in Lee Branch. Now, Village Dermatology is excited to announce that it will be opening its doors to patients in the Gardendale area.

“We are extremely excited about serving the Gardendale area,” explained Physician Owner, Dr. Jenny Sobera. “Everyone on the team here at Village Dermatology feels that the Gardendale area is an under-served part of the Birmingham-Metro area. We are blessed to have the ability and human resources to serve our neighbors in this area moving forward.”    

Village Dermatology is one of the largest dermatology practices in the Birmingham area. Given the need for dermatology services in general, they continue to look for areas to serve the community better strategically. “We continue to move forward despite everything that is going on in the world. I am very proud of our team and providers for making this goal of ours become a reality,” explained Practice Administrator, Audrey Easterwood. “Our goal is to become an integral part of the healthcare services in the Gardendale area.”

About Village Dermatology: Village Dermatology was founded in 2008 by Dr. Jenny Sobera. Dr. Sobera had the vision to bring world-class dermatology to her native home of Birmingham, AL. The practice’s motto of “live a beautiful life” is on display from the moment you walk through the door at Village Dermatology. Since 2008 Village Dermatology has seen thousands of medical and cosmetic patients. Village Dermatology has 3 locations for your convenience: 2900 Cahaba Road, Mountain Brook, AL 35223; 201 Doug Baker Boulevard, Birmingham, AL 35242; 2217 Decatur Highway, Suite 123, Gardendale, AL 35071; and 150 Gilbreath Drive, Oneonta, AL 35121. Learn more at http://www.villagedermatology.net.

If you are in the Gardendale, AL area, and need dermatology services, then please contact Village Dermatology at (205) 877-9773 or visit http://www.villagedermatology.net for more information.

Share article on social media or email: